Warfarin Sensitivity Testing: Medco/Mayo Study Results Due Early 2010

Medco is planning to release an observational study in early 2010 on the benefits of pharmacogenomic testing in warfarin dosing. It hopes the results will increase payer acceptance of the approach to treatment